Full Press Release Details
SECOND ADDENDUM TO THE
NLS Pharmaceutics AG
(Borrower and Lender each a Party
collectively the Parties )
the Parties agree as follows:
The Maturity Date of the Loan Agreement
shall be extended until June 30, 2025. For the avoidance of doubt, the Maturity Date provided in section 1 (ii) in the amended Loan Agreement
pursuant to Annex B shall remain unchanged.
This Agreement shall enter into force
on the Effective Date.
The other terms of the Loan Agreement
shall remain unchanged.
This Agreement shall in all respects
be governed by and construed in accordance with the substantive laws of Switzerland.
All disputes arising out of or in
connection with this Agreement, including disputes regarding its conclusion, validity, binding effect, amendment, breach, termination
or rescission shall be subject to the exclusive jurisdiction of the ordinary courts of Zurich, canton of Zurich, Switzerland, venue being
[signature page and annex follows]
IN WITNESS WHEREOF, the Parties have signed
this Agreement on the date first written above:
| Borrower: NLS Pharmaceutics AG | ||
| /s/ Alexander Zwyer | /s/ Elena Thyen | |
| Name: Alexander Zwyer | Name: Elena Thyen | |
| Function: CEO | Function: CFO | |
| Lender: | ||
| /s/ Ronald Hafner | ||
| Ronald Hafner |
Annex A: Loan Agreement.
Annex B: First Addendum.